Analyst firms · Guggenheim · ACET

Guggenheim ACET price target and rating history

Adicet Bio Inc. (ACET) · Health Care

Guggenheim rates Adicet Bio Inc. (ACET) Buy with a $7 price target, as of its latest action on Sep 30, 2024. It has published 3 rating actions on ACET since December 2021, including 0 upgrades and 1 downgrade.

Current rating
Buy
Price target
$7
Median target, all firms
Too few
Actions on ACET
3

Guggenheim price target on ACET

$32$20$720222023202420252026
Guggenheim price target on ACET, each point a stated target, December 2021 to September 2024.

Every Guggenheim rating on ACET

Questions about Guggenheim and ACET

What is Guggenheim's price target for ACET?
Guggenheim's latest stated price target for Adicet Bio Inc. (ACET) is $7, from its action on Sep 30, 2024.
What is Guggenheim's rating on ACET?
Guggenheim rates ACET Buy, a bullish rating, as of Sep 30, 2024.
When did Guggenheim last change its view on ACET?
On Sep 30, 2024, Guggenheim resumes coverage at Buy, price target $7.

All Guggenheim ratingsACET news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.